Boundless Bio, Inc.

BOLD · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$14-$16-$16-$16
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$2$2$2
Change in WC$2$2-$1-$1
Other Non-Cash$0$0$0-$0
Operating Cash Flow-$10-$12-$15-$16
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$40-$44-$53-$47
Inv. Sales/Matur.$50$55$56$50
Other Inv. Act.$0$0$0$0
Investing Cash Flow$10$11$3$2
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash$0-$0-$11-$14
Supplemental Information
Beg. Cash$15$16$27$41
End Cash$16$15$16$27
Free Cash Flow-$10-$12-$15-$16
Boundless Bio, Inc. (BOLD) Financial Statements & Key Stats | AlphaPilot